These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 11555063)

  • 21. Chronic obstructive pulmonary disease with mild airflow limitation: current knowledge and proposal for future research - a consensus document from six scientific societies.
    Rossi A; Butorac-Petanjek B; Chilosi M; Cosío BG; Flezar M; Koulouris N; Marin J; Miculinic N; Polese G; Samaržija M; Skrgat S; Vassilakopoulos T; Vukić-Dugac A; Zakynthinos S; Miravitlles M
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2593-2610. PubMed ID: 28919728
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Frequency of self-reported COPD exacerbation and airflow obstruction in five Latin American cities: the Proyecto Latinoamericano de Investigacion en Obstruccion Pulmonar (PLATINO) study.
    Montes de Oca M; Tálamo C; Halbert RJ; Perez-Padilla R; Lopez MV; Muiño A; Jardim JRB; Valdivia G; Pertuzé J; Moreno D; Menezes AMB
    Chest; 2009 Jul; 136(1):71-78. PubMed ID: 19349388
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sex differences in the clinical presentation and management of airflow obstruction.
    Dales RE; Mehdizadeh A; Aaron SD; Vandemheen KL; Clinch J
    Eur Respir J; 2006 Aug; 28(2):319-22. PubMed ID: 16880366
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dyspnea in Community-Dwelling Older Persons: A Multifactorial Geriatric Health Condition.
    Miner B; Tinetti ME; Van Ness PH; Han L; Leo-Summers L; Newman AB; Lee PJ; Vaz Fragoso CA
    J Am Geriatr Soc; 2016 Oct; 64(10):2042-2050. PubMed ID: 27549914
    [TBL] [Abstract][Full Text] [Related]  

  • 25. What role may symptoms play in the diagnosis of airflow limitation? A study in an elderly population.
    Medbø A; Melbye H
    Scand J Prim Health Care; 2008; 26(2):92-8. PubMed ID: 18570007
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Do respiratory symptoms predict chronic airflow obstruction and bronchial hyperresponsiveness in older adults?
    Renwick DS; Connolly MJ
    J Gerontol A Biol Sci Med Sci; 1999 Mar; 54(3):M136-9. PubMed ID: 10191841
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of chronic airflow obstruction in a working population.
    Roche N; Dalmay F; Perez T; Kuntz C; Vergnenègre A; Neukirch F; Giordanella JP; Huchon G
    Eur Respir J; 2008 Jun; 31(6):1227-33. PubMed ID: 18216058
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atopy in people aged 40 years and over: Relation to airflow limitation.
    Guevara-Rattray EM; Garden FL; James AL; Wood-Baker R; Abramson MJ; Johns DP; Sonia Buist A; Burney PGJ; Haydn Walters E; Toelle BG; Marks GB
    Clin Exp Allergy; 2017 Dec; 47(12):1625-1630. PubMed ID: 28972658
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessing two spirometric criteria of pre-bronchodilator and post-bronchodilator FEV1/FVC ratio in detecting air flow obstruction.
    Waheed Z; Irfan M; Haque AS; Siddiqui NH; Awan S; Syed B; Khan JA
    J Pak Med Assoc; 2011 Dec; 61(12):1172-5. PubMed ID: 22355960
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of airflow limitation in subjects undergoing comprehensive health examination in Japan: Survey of Chronic Obstructive pulmonary disease Patients Epidemiology in Japan.
    Omori H; Kaise T; Suzuki T; Hagan G
    Int J Chron Obstruct Pulmon Dis; 2016; 11():873-80. PubMed ID: 27217740
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence of airflow limitation in subjects 65-100 years of age.
    Luoto JA; Elmståhl S; Wollmer P; Pihlsgård M
    Eur Respir J; 2016 Feb; 47(2):461-72. PubMed ID: 26677939
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Airflow obstruction, atherosclerosis and cardiovascular risk factors in the AGES Reykjavik study.
    Gudmundsson G; Margretardottir OB; Sigurdsson MI; Harris TB; Launer LJ; Sigurdsson S; Olafsson O; Aspelund T; Gudnason V
    Atherosclerosis; 2016 Sep; 252():122-127. PubMed ID: 27522264
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Obesity is a risk factor for dyspnea but not for airflow obstruction.
    Sin DD; Jones RL; Man SF
    Arch Intern Med; 2002 Jul; 162(13):1477-81. PubMed ID: 12090884
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Asthma, airflow limitation and mortality risk in the general population.
    Huang S; Vasquez MM; Halonen M; Martinez FD; Guerra S
    Eur Respir J; 2015 Feb; 45(2):338-46. PubMed ID: 25323227
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alternative functional criteria to assess airflow-limitation reversibility in asthma.
    Tavares e Castro A; Matos P; Tavares B; Matos MJ; Segorbe-Luís A
    Rev Port Pneumol (2006); 2015; 21(2):69-75. PubMed ID: 25926369
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The relationship between the COPD Assessment Test score and airflow limitation in Japan in patients aged over 40 years with a smoking history.
    Yoshimoto D; Nakano Y; Onishi K; Hagan G; Jones P
    Int J Chron Obstruct Pulmon Dis; 2014; 9():1357-63. PubMed ID: 25525353
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of airflow obstruction and reduced forced vital capacity in an Aboriginal Australian population: The cross-sectional BOLD study.
    Cooksley NA; Atkinson D; Marks GB; Toelle BG; Reeve D; Johns DP; Abramson MJ; Burton DL; James AL; Wood-Baker R; Walters EH; Buist AS; Maguire GP
    Respirology; 2015 Jul; 20(5):766-74. PubMed ID: 25704620
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comorbidities in obstructive lung disease in Korea: data from the fourth and fifth Korean National Health and Nutrition Examination Survey.
    Park HJ; Leem AY; Lee SH; Song JH; Park MS; Kim YS; Kim SK; Chang J; Chung KS
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1571-82. PubMed ID: 26300636
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Health status perception and airflow obstruction in five Latin American cities: the PLATINO study.
    Montes de Oca M; Tálamo C; Halbert RJ; Perez-Padilla R; Lopez MV; Muiño A; Jardim JR; Valdivia G; Pertuzé J; Moreno D; Menezes AM;
    Respir Med; 2009 Sep; 103(9):1376-82. PubMed ID: 19364640
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of twice-daily glycopyrrolate in patients with stable, symptomatic COPD with moderate-to-severe airflow limitation: the GEM1 study.
    LaForce C; Feldman G; Spangenthal S; Eckert JH; Henley M; Patalano F; D'Andrea P
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1233-43. PubMed ID: 27354782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.